ACS Pharmacology & Translational Science,
Journal Year:
2023,
Volume and Issue:
6(11), P. 1616 - 1631
Published: Oct. 11, 2023
Introduction
-
Several
11C-tracers
have
demonstrated
high
potential
in
early
diagnostic
PET
imaging
applications
of
neurodegenerative
diseases
including
Alzheimer's
and
Parkinson's
disease.
These
radiotracers
often
track
critical
biomarkers
disease
pathogenesis
such
as
tau
fibrils
([11C]PBB3)
or
β-amyloid
plaques
([11C]PiB)
associated
with
diseases.
Purpose
The
short
review
aims
to
serve
a
guideline
the
future
development
for
students,
postdocs
and/or
new
radiochemists
who
will
be
synthesizing
clinical
grade
novel
research
11C-tracers,
knowledge
regulatory
requirements.
We
aim
bridge
gap
between
established
11C-tracer
quality
control
(QC)
processes
through
exploring
design
process
requirements
11C-pharmaceuticals.
Methods
A
literature
survey
was
undertaken
identify
articles
detailed
description
QC
methodology
characterization
each
sections
review.
Overview
First
general
summary
production
presented;
this
used
establish
possible
places
contamination
assurances
sterile
final
product.
key
mandated
analyses
use
were
then
discussed.
Further,
we
assessed
methods
reviewed
routine
tests
preclinical
translational
validation
studies.
Therefore,
both
animal
studies
reviewed.
Last,
some
examples
optimization
automation
reviewed,
implications
practices
procedures
considered.
Conclusion
All
common
parameters
under
settings
(along
few
exceptions)
discussed
detail.
While
it
is
important
standard,
peer-reviewed
testing
protocols
entering
umbrella,
equal
importance
needed
on
address
credibility
repeatability
study.
Frontiers in Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: April 9, 2024
Introduction
Dopamine
D3
receptor
(D3R)
ligands
have
been
studied
for
the
possible
treatment
of
neurological
and
neuropsychiatric
disorders.
However,
selective
D3R
radioligands
in
vitro
binding
studies
challenging
to
identify
due
high
structural
similarity
between
D2R
D3R.
In
a
prior
study,
we
reported
new
conformationally-flexible
benzamide
scaffold
having
affinity
excellent
selectivity
vs.
D2R.
current
characterized
properties
radioiodinated
ligand,
[
125
I]HY-3-24.
Methods
were
conducted
cell
lines
expressing
receptors,
rat
striatal
homogenates,
non-human
primate
(NHP)
brain
tissues
measure
regional
distribution
this
radioligand.
Results
HY-3-24
showed
potency
at
(
K
i
=
0.67
±
0.11
nM,
IC
50
1.5
0.58
nM)
compared
other
D2-like
dopamine
subtypes
(D2R
86.7
11.9
nM
D4R
>
1,000).
The
d
(0.34
0.22
B
max
(38.91
2.39
fmol/mg)
values
I]HY-3-24
determined.
homogenates
using
antagonists
confirmed
Autoradiography
results
demonstrated
that
specifically
binds
D3Rs
nucleus
accumbens,
islands
Calleja,
caudate
putamen
NHP
sections.
Conclusion
These
suggest
appears
be
novel
radioligand
exhibits
D3R,
with
low
receptors.
It
is
anticipated
can
used
as
specific
ACS Pharmacology & Translational Science,
Journal Year:
2023,
Volume and Issue:
6(11), P. 1616 - 1631
Published: Oct. 11, 2023
Introduction
-
Several
11C-tracers
have
demonstrated
high
potential
in
early
diagnostic
PET
imaging
applications
of
neurodegenerative
diseases
including
Alzheimer's
and
Parkinson's
disease.
These
radiotracers
often
track
critical
biomarkers
disease
pathogenesis
such
as
tau
fibrils
([11C]PBB3)
or
β-amyloid
plaques
([11C]PiB)
associated
with
diseases.
Purpose
The
short
review
aims
to
serve
a
guideline
the
future
development
for
students,
postdocs
and/or
new
radiochemists
who
will
be
synthesizing
clinical
grade
novel
research
11C-tracers,
knowledge
regulatory
requirements.
We
aim
bridge
gap
between
established
11C-tracer
quality
control
(QC)
processes
through
exploring
design
process
requirements
11C-pharmaceuticals.
Methods
A
literature
survey
was
undertaken
identify
articles
detailed
description
QC
methodology
characterization
each
sections
review.
Overview
First
general
summary
production
presented;
this
used
establish
possible
places
contamination
assurances
sterile
final
product.
key
mandated
analyses
use
were
then
discussed.
Further,
we
assessed
methods
reviewed
routine
tests
preclinical
translational
validation
studies.
Therefore,
both
animal
studies
reviewed.
Last,
some
examples
optimization
automation
reviewed,
implications
practices
procedures
considered.
Conclusion
All
common
parameters
under
settings
(along
few
exceptions)
discussed
detail.
While
it
is
important
standard,
peer-reviewed
testing
protocols
entering
umbrella,
equal
importance
needed
on
address
credibility
repeatability
study.